AnaptysBio, Inc. ANAB Unrealized Gain (Loss) on Investments
Unrealized Gain (Loss) on Investments at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s unrealized gain (loss) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s unrealized gain (loss) on investments?
- AnaptysBio, Inc. (ANAB) reported unrealized gain (loss) on investments of $8K in Q1 2026.
- How has AnaptysBio, Inc.'s unrealized gain (loss) on investments changed year-over-year?
- AnaptysBio, Inc.'s unrealized gain (loss) on investments decreased by 99.5% year-over-year, from $1.67M to $8K.
- What is the long-term trend for AnaptysBio, Inc.'s unrealized gain (loss) on investments?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s unrealized gain (loss) on investments has grown at a 76.0% compound annual growth rate (CAGR), from -$493K to $4.73M.